GX Acquisiton
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GX Acquisiton and buy or sell other stocks, ETFs, and their options commission-free!About GXGX
Celularity, Inc. is a clinical stage biotechnology company, which engages in the development of off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer and immune and infectious diseases. It operates through the following segments: Cell Therapy, BioBanking, Degenerative Disease, and Other.
CEORobert Joseph Hariri Gordon, MD, PhD
CEORobert Joseph Hariri Gordon, MD, PhD
Employees123
Employees123
HeadquartersFlorham Park, New Jersey
HeadquartersFlorham Park, New Jersey
Founded2016
Founded2016
Employees123
Employees123
GXGX Key Statistics
Market cap13.33M
Market cap13.33M
Price-Earnings ratio-0.50
Price-Earnings ratio-0.50
Dividend yield—
Dividend yield—
Average volume53.25K
Average volume53.25K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$4.35
52 Week high$4.35
52 Week low$1.00
52 Week low$1.00
Stock Snapshot
With a market cap of 13.33M, GX Acquisiton(GXGX) trades at $0.47. The stock has a price-to-earnings ratio of -0.50.
On 2025-12-12, GX Acquisiton(GXGX) stock opened at —, reached a high of —, and a low of —.
The GX Acquisiton(GXGX)'s current trading volume is 0, compared to an average daily volume of 53.25K.
During the past year, GX Acquisiton(GXGX) stock moved between $1.00 at its lowest and $4.35 at its peak.
During the past year, GX Acquisiton(GXGX) stock moved between $1.00 at its lowest and $4.35 at its peak.
People also own
Based on the portfolios of people who own GXGX. This list is generated using Robinhood data, and it’s not a recommendation.